Ahead of Consensus.
Intelligence across tech and capital markets, for investors, policymakers, and business leaders.
9 minute read
On July 22, X-energy became a name attached to something larger than itself. The Rockville, Maryland-based reactor developer was named a founding Tier 1 partner of Project Prometheus, a research initiative organized around a proposition Washington has decided to test with real money: that artificial intelligence can shorten the distance between a reactor design and a working power plant. X-energy’s price of admission was $10 million in private capital, a seat on the initiative’s board, and access to its most valuable asset, the design and fuel fabrication data behind its Xe-100 reactor.
That last detail matters more than the capital commitment. X-energy did not need Prometheus’s money. It needed a place inside the room where the rules for AI-assisted nuclear licensing get written, and it paid for that seat with the one thing competitors cannot easily replicate: a decade of proprietary engineering data on a reactor design already working its way through the Nuclear Regulatory Commission.
The company arrives with preparation of its own. It has spent recent months building APEX, an internal multi-agentic AI platform now running across its engineering, licensing, and operations teams, work the company says has already compressed the time required for routine technical review. Chief executive J. Clay Sell, who has run X-energy since 2019 and previously served as Deputy Secretary of Energy under President George W. Bush, described the partnership as consistent with a strategy the company has pursued since well before artificial intelligence became the industry’s preferred vocabulary: get inside the infrastructure buildout early, and let scale follow.
Prometheus did not appear from nowhere. It is a product of the Genesis Mission, the Department of Energy’s AI-for-science program, born of a late-2025 executive order that framed the effort in terms usually reserved for wartime industrial policy. The department opened applications in March, structured in two tiers: smaller Phase I awards meant to seed early work, and larger Phase II awards meant to fund the ideas worth scaling.
Prometheus, administered by Idaho National Laboratory alongside Oak Ridge, Argonne, and Sandia, was the first Phase II award granted, a three-year, $60 million commitment subject to congressional appropriation. Among the 278 awards the department announced at its Washington summit, it was the largest by a wide margin, a distinction that separates it from the university research grants making up most of the list.
The federal number is the smallest part of the arithmetic. Idaho National Laboratory’s own release puts industry cost share at more than $200 million, with a further $30 million in direct industry capital, a structure that likely explains a $200 million figure Bloomberg reported the night before the announcement and that some readers mistook for a separate appropriation. It is not. It is the private half of a public-private ledger that, taken together, describes a 32-partner coalition spanning four national laboratories, several universities, and more than 20 companies, X-energy, TerraPower, and Oklo among them.
The mandate itself is unusually specific for a government research program: apply AI, with a person still making the final call, to reactor design, licensing, manufacturing, construction, and eventually semi-autonomous operation, while also digitizing decades of fuel fabrication and legacy plant documentation that has never been machine-readable.
Nuclear power’s real bottleneck has rarely been physics. It has been paperwork, precedent, and the sheer volume of documentation a design must generate before a regulator will sign off on it. Advanced reactor licensing in the United States can consume years reviewing analyses that, once submitted, differ only incrementally from the last design iteration. An AI system trained on that documentation, with regulators comfortable trusting its output, could compress review cycles that have nothing to do with whether a reactor is safe and everything to do with how slowly institutions read.
That is the wager behind X-energy’s participation, and it explains why a company already carrying an 11.5 gigawatt commercial pipeline, roughly 144 Xe-100 units across the United States and the United Kingdom, would trade proprietary data for a seat at a research table rather than simply build faster on its own. The pipeline itself, anchored by Dow, Amazon, and the UK’s Centrica, remains largely conditional. Amazon’s option to deploy more than 5 gigawatts by 2039, tied to its Energy Northwest partnership, is the single agreement that has done the most to validate the Xe-100 commercially, but validation is not construction. The Dow project in Texas and the Hanford, Washington deployment are both still moving through licensing, and X-energy only entered the United Kingdom’s Generic Design Assessment process in June.
Prometheus, in that light, is not a new revenue stream. It is an attempt to insure a multi-year pipeline against the one risk that has quietly punished every advanced reactor developer before it: schedule slippage measured not in months but in license-review cycles.
Markets, characteristically, arrived at their own conclusion before the government finished writing its announcement. X-energy priced its April IPO at $23 a share, 21 percent above the marketed range, and its stock climbed as high as $13.7 billion in intraday value on debut day, an outcome that closed the door on the memory of a 2023 SPAC merger, worth barely a tenth as much, that had collapsed for lack of investor appetite.
That appetite has since proven conditional. First-quarter results in June showed revenue of $43.4 million, up 109 percent year over year but well below the $67.87 million analysts expected, while operating expenses more than doubled to $109.5 million on the cost of advancing its Advanced Reactor Demonstration Program work. Shares fell to a 52-week low of $13.29 on July 16.
Then came the leak. A Bloomberg report on the evening of July 21 describing a federal program pairing X-energy and Oklo with Microsoft and Nvidia sent shares up as much as 7 percent after hours. By Wednesday’s close, most of that gain had evaporated: X-energy finished the regular session down 2 percent, near $16.45, before recovering a modest 2.6 percent once the official announcement confirmed what the leak had already priced in. The round trip, in barely 24 hours, said less about Prometheus than about a stock still searching for a level investors trust.
There is also a political dimension worth weighing. The $60 million award remains subject to congressional appropriation, a caveat easy to overlook amid the fanfare of a Washington summit but material to any three-year federal commitment. And because Oklo and TerraPower sit inside the same 32-partner coalition, whatever Prometheus produces will not belong to X-energy alone. The research is public infrastructure, not proprietary advantage, and the benefit to any single reactor developer will be diluted by the very collaboration that makes it possible.
None of this changes the timeline. Prometheus is a three-year research effort, not a construction accelerant, and X-energy’s first commercial deployments remain scheduled for the early 2030s regardless of what the research produces. Two nearer-term dates will matter more to shareholders: the company’s lock-up expires early, on September 1, adding potential supply to a stock already trading well under its offering price, and second-quarter results will show whether the cost growth visible in the first quarter is stabilizing or still building.
Prometheus lends X-energy credibility it could not have purchased on its own. It does not, by itself, shorten the distance to a reactor that generates revenue. For a sector still asking investors to underwrite an outcome years away, that distinction, between validation and delivery, is the one worth watching most closely.